A sharp correction in Bitcoin prices has pushed MicroStrategy's massive holdings into significant paper losses, testing the resolve of the corporate sector's most vocal crypto advocate and raising questions about the sustainability of its accumulation strategy.
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
French IT giant Capgemini moves to sell its U.S. government solutions subsidiary following political and internal pressure over its contract with Immigration and Customs Enforcement (ICE), as public debate intensifies around tech's role in immigration enforcement.
Backed by a major U.S. government loan and a surge in private equity, USA Rare Earth is accelerating its domestic mining and manufacturing projects, positioning itself at the forefront of a critical national strategy.
Backed by regional sovereign wealth giants, Ruya Partners is launching a $400 million fund to address middle-market lending gaps in Saudi Arabia and the UAE, positioning itself as a key player in the Gulf's burgeoning private credit landscape.
Chinese authorities have executed four individuals convicted of leading a massive online fraud and gambling ring based in Myanmar, linked to over $4 billion in illicit proceeds and the deaths of six Chinese nationals. The move is part of a widening crackdown on cross-border criminal networks targeting Chinese citizens.
Amidst a patchy economic recovery, European small-cap stocks are back in focus. A surge in insider buying activity points to potential undervaluation in select names across property, cybersecurity, and defense tech sectors.
Alibaba Group has announced a massive 3 billion yuan ($431 million) campaign to promote its Qwen AI app during the upcoming Lunar New Year holiday, significantly outpacing similar efforts by rivals Tencent and Baidu. The move intensifies a high-stakes battle for user adoption in China's rapidly evolving artificial intelligence sector.
Amid a patchy market recovery, savvy investors are scouring Europe for hidden gems. We spotlight three companies—from shipping to sportswear—whose current share prices appear significantly discounted against their intrinsic value, presenting potential opportunities for long-term growth.
As confidence in the Eurozone's recovery builds, investors are scrutinizing companies where executives hold significant equity stakes—a potential signal of alignment and long-term conviction. We spotlight three firms from a broader screen of 220 high-insider-ownership growth stocks.
Amidst a cautiously recovering Eurozone economy, we spotlight three lesser-known European companies—spanning finance, telecom, and food production—that combine strong fundamentals with compelling growth narratives for discerning investors.
While the UK kitchenware retailer maintains sales growth, a five-year decline in a key profitability metric and rising liabilities signal potential headwinds for investors.
The London-listed gold miner AltynGold is turning heads with a remarkable 43% return on capital employed, significantly outpacing industry averages and fueling investor optimism about its expansion potential.
While 'story stocks' captivate with promise, Begbies Traynor Group (LON:BEG) is drawing a different kind of investor attention. The UK-based business recovery and insolvency specialist is showcasing strong earnings growth, expanding margins, and significant insider investment, positioning it as a notable contender in the current market landscape.
A fabricated email alleging Jeffrey Epstein discussed Bitcoin's launch with Ghislaine Maxwell has spread online. While the viral message is false, newly released court documents contain genuine references to the cryptocurrency's pseudonymous founder.
A surge of competitively priced Chinese electric vehicles and consumer goods is rapidly transforming Latin American markets, forcing governments from Mexico to Brazil to enact new tariffs and trade defenses to shield domestic industries from the influx.
In a tense Sunday interview, ABC's George Stephanopoulos confronted Deputy Attorney General Todd Blanche about a Wall Street Journal investigation revealing a major investment by a UAE security official into a cryptocurrency company founded by Donald Trump.
Shares of security products giant Allegion have gained significant momentum, delivering a 26% total return over the past year. With the stock now trading near $165, we examine whether its current valuation still offers an attractive entry point or if future growth is already priced in.
Shares of Tyson Foods (TSN) have climbed over 12% in the past month, reigniting discussions on Wall Street about the meatpacking giant's valuation. While some analysts see room for further growth, others caution that recent gains may have outpaced fundamentals.
Takeda Pharmaceutical's (TSE:4502) recent share price rally has ignited a debate among investors. With the stock closing at ¥5,242, analysts are divided on its true worth, presenting a complex picture of fair value signals and future growth prospects.
